Fda, Food And Drug Administration | featured news

FDA approves new targeted breast cancer drug

Roche

The Food and Drug Administration says it has approved a new form of a best-selling breast cancer drug that targets tumor cells while sparing healthy ones. The drug Kadcyla (kad-SY'-luh) from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a double-shot of anti-tumor poison.

 

FDA took 684 days to warn plant tied to meningitis

The U.S. Food and Drug Administration took 684 days to issue a warning letter after uncovering serious issues at the pharmacy at the center of the deadly U.S. meningitis outbreak, newly released documents showed.

 

Health roundup: Arsenic in rice raises concerns

Rice

Consumer Reports is calling on the Food and Drug Administration to set standards for how much arsenic can be allowed in rice after finding the potential toxin in almost every rice product it tested. FDA is running its own tests and says it would be premature to set standards or to urge consumers to change their eating habits. Rice producers say there's no documented evidence of health harm from arsenic in rice grown in the United States.

 

FDA approves first pill to help prevent HIV

Truvada

The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, the latest milestone in the 30-year battle against the virus that causes AIDS....

 

FDA clears first new weight-loss pill in 13 years

The Food and Drug Administration has approved Arena Pharmaceutical's anti-obesity pill Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade.

 

FDA rejects bid to rename high-fructose corn syrup 'corn sugar'

The Food and Drug Administration rejected a petition from the Corn Refiners Assn. to rename high-fructose corn syrup “corn sugar,” saying that the change could confuse consumers and “pose a public health concern.”

 

HHS overrules FDA, blocks over-the-counter Plan B for younger teens

Plan B Emergency Contraceptive

The emergency contraceptive Plan B will not be made available over-the-counter to younger teens, the Food and Drug Administration announced today, exposing a rift between the agency and the U.S. Department of Health and Human Services.

 

FDA questions studies of breast implant safety

FDA questions studies of breast implant safety

A U.S. Food and Drug Administration advisory panel began a two-day meeting Tuesday on silicone breast implants to consider ways to improve the effectiveness of post-approval safety studies.

 

FDA questions safety of experimental diabetes drug

Federal health regulators have concerns about bladder and breast cancer seen in patients taking an experimental diabetes pill from Bristol-Myers ...

 

FDA to hear appeal on breast cancer drug Avastin

The best-selling cancer drug in the world comes under federal scrutiny as drugmaker Roche makes a last-ditch effort to keep Avastin approved ...

 

Subscribe to this RSS topic: Syndicate content